Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Nee...
Tevogen Bio Holdings Inc. (TVGN)
Company Research
Source: Business Wire
WARREN, N.J.--(BUSINESS WIRE)--Tevogen Bio Holdings Inc. ('Tevogen Bio') (Nasdaq: TVGN)Tevogen’s ExacTcell platform was developed to harness the killing ability of naturally occurring cytotoxic T lymphocytes (CTLs), against viral and malignant targets.TVGN 489, a CTL therapy produced by the ExactTcell platform, contains CTLs recognizing multiple protein targets across the SARS-CoV-2 genome. These cells were well tolerated in a completed proof of concept clinical trial in high-risk patients with acute COVID-19, with later stage studies planned in this area.Tevogen plans to assess whether TVGN 489 cells can rapidly eliminate symptoms of Long Covid. To facilitate the development of a Long Covid treatment trial, Tevogen will launch a preliminary study in Q1 2024 to assess whether the development of Long COVID is associated with a key component of an individual’s immune system known as Human Leukocyte Antigens (HLA).TVGN 489 CTLs work in conjunction with HLA molecules to recognize and
Show less
Read more
Impact Snapshot
Event Time:
TVGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TVGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TVGN alerts
High impacting Tevogen Bio Holdings Inc. news events
Weekly update
A roundup of the hottest topics
TVGN
News
- Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives [Yahoo! Finance]Yahoo! Finance
- Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational ObjectivesGlobeNewswire
- Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives [Yahoo! Finance]Yahoo! Finance
- Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational ObjectivesGlobeNewswire
- Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments [Yahoo! Finance]Yahoo! Finance
TVGN
Sec Filings
- 5/2/24 - Form 8-K
- 4/29/24 - Form 8-K/A
- 4/29/24 - Form 10-K
- TVGN's page on the SEC website